Reaction

Application Site Pustules reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 362 reports · 5 co-occurring drugs

As of the last recalculation, Application Site Pustules appears in 362 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is MINOXIDIL FOAM 5% (WOMENS) (PRR 25.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Minoxidil Foam 5% (Womens)1425.325.4
Minoxidil1621.421.4
Buprenorphine2919.519.5
Glycerin, Lidocaine416.616.6
Docosanol415.915.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.